Background and Aim: The amount of proteins and peptides can be estimated with amide proton transfer (APT) imaging. Previous studies demonstrated the usefulness of APT imaging to predict tumor malignancy. We determined whether APT imaging can predict the tumor response to neoadjuvant chemotherapy (NAC) in patients with locally advanced rectal cancer (LARC). Methods: Seventeen patients with LARC who underwent a pretherapeutic magnetic resonance examination including APT imaging and NAC (at least two courses) were enrolled. The APT-weighted imaging (WI) signal intensity (SI) (%) was defined as magnetization transfer ratio asymmetry (MTR asym ) at the offset of 3.5 ppm. Each tumor was histologically evaluated for the degree of degeneration and necrosis and then classified as one of five histological Grades (0, none; 1a, less than 1/3; 1b, 1/3 to 2/3; 2, more than 2/3; 3, all). We compared the mean APTWI SIs of the tumors between the Grade 0/1a/1b (low-response group) and Grade 2/3 (high-response group) by Student's t-test. We used receiver operating characteristics curves to determine the diagnostic performance of the APTWI SI for predicting the tumor response. Results: The mean APTWI SI of the low-response group (n = 12; 3.05 ± 1.61%) was significantly higher than that of the high-response group (n = 5; 1.14 ± 1.13%) (P = 0.029). The area under the curve for predicting the tumor response using the APTWI SI was 0.87. When ≥2.75% was used as an indicator of low-response status, 75% sensitivity and 100% specificity of the APTWI SI were obtained. Conclusion: Pretherapeutic APT imaging can predict the tumor response to NAC in patients with LARC.
Introduction
Colorectal cancer has become one of the leading causes of cancerrelated death, accounting for 30% to 35% of these deaths. 1 The standard treatment for rectal cancer in Western countries is preoperative chemoradiotherapy plus total mesorectal excision. 2 However, preoperative radiotherapy is still not a standard treatment in Japan, 3 and the Japanese guidelines for the treatment of colorectal cancer recommend upfront surgery followed by adjuvant chemotherapy. 4 A shift of part of adjuvant chemotherapy regimens to the preoperative period has recently been considered as an alternative method of treatment. A few studies have already suggested the efficacy and safety of neoadjuvant chemotherapy (NAC) in rectal cancer. 2, 5 However, there is concern that the opportunity for curative surgery may be lost and distant metastasis may occur due to a lack of tumor sensitivity to NAC. 2 Magnetic resonance imaging (MRI) has achieved broad acceptance for the local staging of primary rectal cancer before therapy. 6, 7 Recent MRI techniques can provide not only morphological details of the lesions but also functional parameters with the potential to be applied as imaging biomarkers. For example, diffusion-weighted MRI imaging (DWI) reflects water diffusion characteristics, which are dependent on multiple factors such as cell density, vascularity, the viscosity of extracellular fluid, and cell membrane integrity. 8 DWI expresses these properties as an apparent diffusion coefficient (ADC), and the ADC in turn has proven to be a viable imaging biomarker for prognostic purposes in various malignant tumors. [9] [10] [11] [12] [13] [14] A few reports have suggested the potential of ADC measured preoperatively as a predictor of the response to chemoradiation in rectal cancer, 15, 16 but several conflicting results have also been reported. [17] [18] [19] Thus, a new imaging biomarker to predict the therapeutic effects in rectal cancer is desirable.
Chemical exchange saturation transfer (CEST) has drawn considerable attention as a novel contrast mechanism in MRI. 20, 21 CEST contrast is achieved by applying a saturation pulse at the resonance frequency of a slow intermediate exchanging proton site doi:10.1111/jgh.14315 (ÀNH, ÀOH, or metal-bound water molecule) of endogenous or exogenous agents, and the resulting saturated or partially saturated spin is transferred to bulk water via a chemical exchange. As a result, the signal intensity (SI) of bulk water is reduced, thereby providing negative contrast in an image. Zhou et al. 22 developed amide proton transfer (APT) imaging as an endogenous CEST imaging technique. With this method, the exchange between protons of bulk water and the amide protons (ÀNH) of endogenous mobile proteins and peptides can be imaged. That is, the amount of proteins and peptides can be estimated with APT imaging noninvasively.
Previous studies demonstrated the usefulness of the APT SI to predict the tumor grade in glioma, 23 the Gleason score in prostate cancer, 24 and the differentiation in lung tumors. 25 Because tumor cells have a high proliferative activity and because the protein synthesis is also active in such tumors, the difference in the amount of proteins or peptides may reflect tumor malignancy. A pair of studies suggested that the posttherapeutic APT SI might be useful to the evaluation of treatment effects in glioblastoma and breast cancer. 26, 27 However, considering the characteristics of APT imaging, the pretherapeutic APT SI also could be used to predict the treatment effects. We thus conducted the present study to determine whether pretherapeutic APT imaging can predict tumor responses to NAC in locally advanced rectal cancer.
Methods
Patients. This study was approved by our institutional review board and complied with its ethical committee standards. Written informed consent was obtained from all patients before their enrollment in the study. From April 2012 to June 2015, 61 consecutive adult patients underwent a magnetic resonance (MR) examination including APT imaging for the evaluation of rectal cancer, which was pathologically diagnosed as adenocarcinoma by biopsy under endoscopy. Five patients were excluded due to therapy in other hospitals, three patients due to poor image quality, and two patients due to a small tumor with a diameter of less than 1.0 cm. The remaining 51 patients underwent therapy at our hospital as follows: operation, n = 22; chemotherapy, n = 6; radiation, n = 2; chemotherapy and operation, n = 17; chemoradiation and operation, n = 4.
Among these 51 patients, 17 patients who underwent an operation after NAC were enrolled in this study: 12 men and 5 women (age range 38-79 years; mean age 61 years). The MR examinations were performed within 2 weeks before NAC for all patients. The tumor diameter measured on MR examination ranged 14 to 69 mm with an average value of 40 mm. The three NAC regimens were as follows: mFOLFOX (folinic acid 200 mg/m 2 on day 1, fluorouracil 400 mg/m 2 on day 1, fluorouracil 2400 mg/m 2 on days 1-2, and oxaliplatin 85 mg/m 2 on day 1) for two to seven courses in five patients; XEROX (capecitabine 2000 mg/m 2 on days 1-14 and oxaliplatin 130 mg/m 2 on day 1) for three to six courses in nine patients; and SOX (tegafur/gimeracil/oteracil 100 mg/body on days 1-14 and oxaliplatin 130 mg/m 2 on day 1) for three to four courses in three patients.
Magnetic resonance imaging. Amide proton transfer imaging was performed on a clinical whole-body 3.0-Tesla MR system equipped with dual-source parallel RF transmission technology (Achieva 3.0T TX; Philips Healthcare, Best, the Netherlands). A 32-channel torso-cardiac coil and a parallel imaging technique were used. An intramuscular injection of butylscopolamine (Buscopan 20 mg; Nippon Boehringer Ingelheim, Tokyo) was administered to prevent image degradation due to bowel motion before the patient entered the MR scanner.
Amide proton transfer imaging, in addition to T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), DWI, and contrast-enhanced T1WI, was performed for each patient. The APT imaging was performed before the administration of gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA, Bayer HealthCare, Osaka, Japan).
The acquisition software was modified to alternate the operation of the two transmission channels during the radio frequency (RF) saturation pulse, which enables long quasi-continuous RF saturation beyond the 50% duty cycle of a single RF amplifier, and to allow a special RF shimming for the saturation homogeneity of the alternated pulse. 23, 24 On a single slice corresponding to the maximum cross-sectional area of the tumor, twodimensional axial APT imaging was performed using a saturation pulse with a duration of 0.5 s (10 × 50 ms, sincGaussian-shaped elements) and a saturation power level corresponding to B 1,rms = 2.0 μT. This single slice, on which the tumor appeared to be the largest, was selected as the reference in our comparisons with T1WI, T2WI, and DWI. For acquiring an APT Z-spectrum, the imaging was repeated at 25 saturation frequency offsets from ω = À6.0 to +6.0 ppm with a step of 0.5 ppm as well as one far-off resonant frequency (ω = À1560.0 ppm) for signal normalization. The other MR parameters of the APT imaging were as follows: single-shot fast spin-echo readout with driven equilibrium refocusing; repetition time/echo time (TE), 5000 ms/6 ms; field of view, 230 × 230 mm; spatial resolution, 1.8 × 1.8 × 5.0 mm 3 ; slice thickness, 5 mm; echo train length, 128; sensitivity encoding factor, 2; total scan time, 2 min 20 s for one Z-spectrum. A ΔB 0 map for off-resonance correction was acquired separately using a two-dimensional gradient-echo with identical spatial resolution, and it was used for point-by-point ΔB 0 correction.
The details of the other MR sequences are shown in Table 1 . An ADC map was automatically generated on a mono-exponential model by referring to the SIs of the DWI with the b-values of 0, 500, and 1000 s/mm 2 . For the contrast-enhanced T1WI, the amount of Gd-DTPA was based on the patient's bodyweight (0.2 mL/kg), and the total volume was injected intravenously before scanning.
Data analysis. The APT imaging data were analyzed with the software program Image J (U.S. National Institutes of Health, Baltimore, MD, USA). We used the analysis method reported by Togao et al. 23 A plug-in was created to assess the Z-spectra and magnetization transfer ratio asymmetry (MTR asym ) equipped with a correction function for B 0 inhomogeneity, using interpolation among the Z-spectral image data. First, rigid-body-motion correction was performed using the TurboReg algorithm. 28 The local B 0 field shift, in Hertz, was obtained from the B 0 map, which was created from dual-echo gradient-echo images (TE 1 and 2 ms) according to the following equation:
where phase [TEi](x) indicates the phases of the images with echo times TE1 or TE2 at position x in the radians, and TE1 and TE2 are given in seconds. The ΔB0(x) is the resulting B 0 map measured in Hertz. Each voxel was corrected in image intensity for the nominal saturation frequency offset by Lagrange interpolation among the neighboring Z-spectral images. This procedure corresponds to a frequency shift along the saturation frequency offset axis according to the measured B 0 shift. The MTR was defined as 1 À S sat /S 0 , where S sat and S 0 were the SIs obtained with and without selective saturation, respectively. 20 To reduce these undesired contributions from the conventional MT effect and the direct saturation of bulk water, we performed an asymmetry analysis of MTR with respect to the water frequency.
For the APT imaging, we calculated the asymmetry analysis at 3.5 ppm downfield from the water signal as the MTR asym (3.5 ppm) 20 :
It should be noted that the measured MTR asym (3.5 ppm) is an apparent APT SI, and thus, it is appropriate to define the calculated MTR asym (3.5 ppm) images as APT-weighted images (APTWI). In the present study, we defined the APTWI SI as MTR asym (3.5 ppm) × 100 (%), and we measured it by drawing a regionof-interest (ROI) on the APTWI.
Two experienced radiologists (A.N. and Y.T., with 21 and 15 years of experience in interpreting abdominal MRIs) were blinded to the clinical and pathological data and reviewed all MRI results independently. Each of these radiologists detected a mass or wall thickening showing low intensity on T1WI, slightly high intensity on T2WI, high intensity on DWI, and enhancement on contrastenhanced T1WI on the same single slice with APT imaging. On the software program Image J, with reference to those images, as large a polygonal ROI as possible was carefully placed on the APTWI by each radiologist in the solid component of a tumor, in order to avoid cystic, large necrotic, or hemorrhagic components of the tumor. The size of ROIs placed on APTWI for the measurement of APTWI SIs was ≥260 mm 2 (≥80 pixels). On commercially available PACS workstation (SYNAPSE; FujiFilm Medical, Tokyo), the ADC for each patient was measured by drawing a polygonal ROI on the same slice of the ADC map. The radiologists made their best effort to carefully place the ROI at the same region measured on the APTWI. The APTWI SIs and ADCs in all patients were recorded. The average values of the APTWI SIs and ADCs measured by the two radiologists were used for the statistical analyses.
Pathological evaluation. For each patient, the pathological diagnosis was determined by three experienced pathologists (Y.K., T.H. and M.H., 4, 4 and 10 years of experience as pathologists) using tumor specimens removed at surgical resection. These specimens were fixed in 10% formalin, cut into 4-μm sections, and stained with HE. The pathologists semiquantitatively evaluated the specimens' degree of histological degeneration and necrosis after NAC according to the method described in the Japanese Classification of Colorectal Carcinoma 2009, 29 which is as follows: Grade 0, none; Grade 1a, less than 1/3; Grade 1b, 1/3 to 2/3; Grade 2, more than 2/3; Grade 3, all. The tumor grades were determined by consensus by the three pathologists. We defined Grades 0, 1a, and 1b as the tumor low-response group, and Grades 2 and 3 were defined as the tumor high-response group.
Statistical analysis. We determined the intraclass correlation coefficient (ICC) of the APTWI SIs and that of the ADCs measured by the two radiologists. Interobserver agreement is Utility of APT imaging in rectal cancer A Nishie et al.
considered to be excellent if an ICC is >0.74. 30 The average APTWI SIs and the average ADCs were compared between the low-response and high-response groups with a Student's t-test. When a significant difference was obtained between the two groups, we also evaluated the ability to predict low-response status by performing a receiver operating characteristic curve analysis. The feasible cut-off point of the APTWI SI or the ADC was determined using the point on the curve closest to the (0, 1) point. 31 The sensitivity was defined as the percentage of cases, which showed an APTWI SI equal to or greater than the given threshold level in the low-response group. The specificity was defined as the percentage of cases, which showed an APTWI SI smaller than the given threshold level in the high-response group. P-values of <0.05 were accepted as significant.
Results
Reproducibility of the amide proton transferweighted imaging signal intensity and the apparent diffusion coefficient. An ADC value was unavailable in one case due to lack of DWI scanning. The range of the average APTWI SI values (%) was 0.1-5.6, and the range of the average ADCs (×10 À3 mm 2 /s) was 0.85-1.31. The ICC for the APTWI SI was 0.95 (P < 0.0001) and that for the ADC was 0.17 (P = 0.26). The interobserver agreement for the APTWI SI was judged to be excellent.
Relationship between the amide proton transferweighted imaging signal intensity and tumor response. The degrees of histological degeneration and necrosis after NAC were as follows: Grade 0 in one case, Grade 1a in eleven, Grade 2 in four, and Grade 3 in one. As a result, the low-response and high-response groups consisted of 12 and 5 cases, respectively. The mean APTWI SI of the low-response group (3.05 ± 1.61%) was significantly higher than that of the high-response group (1.14 ± 1.13%) (P = 0.029) (Fig. 1a) . The area under the curve for predicting the tumor response using the APTWI SI was 0.87 (Fig. 2) . When ≥2.75% was used as an indicator of low-response status, 75% sensitivity and 100% specificity of the APTWI SI were obtained.
Relationship between the apparent diffusion coefficient and tumor response. There was no significant difference in ADC values between the low-response (1.02 ± 0.13 × 10 À3 mm 2 /s; n = 11) and high-response (1.04 ± 0.13 × 10 À3 mm 2 /s; n = 5) groups (P > 0.05) (Fig. 1b) . Representative cases are illustrated in Figures 3 and 4 . Figure 1 (a) Comparison of the APTWI SIs between the low-response (n = 12) and high-response (n = 5) groups. The mean APTWI SI of the lowresponse group (3.05 ± 1.61%) was significantly higher than that of the high-response group (1.14 ± 1.13%) (P = 0.029). (b) Comparison of the ADCs between the low-response and high-response groups. There was no significant difference in ADC between the low-response (1.02 ± 0.13 × 10 À3 mm 2 / s) and high-response (1.04 ± 0.13 × 10 À3 mm 2 /s) response groups (P > 0.05). An ADC value was unavailable in one case due to lack of DWI scanning.
ADC, apparent diffusion coefficient; APTWI SI, amide proton transfer-weighted imaging signal intensity. [Color figure can be viewed at wileyonlinelibrary.com] Figure 2 Determination of the feasible cut-off point of the amide proton transfer-weighted imaging signal intensity to predict low-response status, with a receiver operating characteristic curve. The area under the curve was 0.87. The feasible cut-off point of amide proton transferweighted imaging signal intensity was determined using the point on the curve closest to the (0, 1) point and was observed to be 2.75%.
[Color figure can be viewed at wileyonlinelibrary.com]
Discussion
We observed that the mean APTWI SI of the present low-response group was significantly higher than that of the high-response group. In addition, when the feasible cut-off point of APTWI SI was set, the diagnostic potential of the APTWI SI for the prediction of low-response status was high. These results suggest that APT imaging can be used for the prediction of tumor response to NAC. The previous reports may account for them. First, in general, tumors with higher malignancy show high APT SIs because of an increased protein synthesis accompanied by cell division and cellular density. 23, 25 Second, rectal adenocarcinoma is known to include mucin in the intracellular and extracellular spaces. 32 Tumors including mucin (abundant extracellular/intracellular protein), which are thought to show high APT SIs, have been reported to be unresponsive to chemotherapy. 2, 33 Last, for oncology, acidic extracellular pH can induce the invasiveness of tumor cells into the stroma. 34 APT imaging is also sensitive to pH. For example, the APT SI of ischemic (acidosis) areas in the brain is reported to decrease. 35 To some degree, intratumoral pH can affect tumor malignancy. We assume that many complicated factors may be associated with the high APTWI SIs in the tumors of the present low-response to NAC status. The high reproducibility of APTWI SIs measured by two radiologists in this study enables the clinical application of the APTWI SI, and APT imaging may contribute to the selection of a therapeutic strategy, that is, a personalized therapy for patients with rectal cancer. There is concern that the opportunity for curative surgery may be lost, and distant metastasis may occur due to a lack of tumor sensitivity to NAC. 2 This is the first report to suggest that APT imaging scanned before treatment may be useful to predict therapeutic effects in malignant tumors.
Contrarily, we observed no significant difference in ADCs between the low-response and high-response groups. We have a plausible hypothesis regarding this result. The ADC reportedly can distinguish poorly differentiated adenocarcinoma from welldifferentiated adenocarcinoma in rectal cancer, 32, 36 that is, more malignant tumors showed low ADC due to increased cell density. However, the ADCs of tumors including abundant extracellular/intracellular protein such as mucin are considered to be rather high. Tumors that do not respond to chemotherapy can show a low or high ADC. Therefore, the ADC in rectal cancer may not be useful for the prediction of tumor response to NAC. Moreover, the reproducibility of the ADCs measured by two radiologists was not high. Due to the low spatial resolution of DWI, a slight difference in the placement of ROIs would lead to a large difference in the measurement of ADCs. For predicting tumor responses, the APTWI SI could be superior to the ADC. 
Utility of APT imaging in rectal cancer
Dynamic contrast-enhanced MRI is also reportedly useful to predict tumor response after chemoradiotherapy. Tong et al. 37 reported that K trans of pretreatment MRI was a perfusion parameter that could discriminate complete pathological response (pCR) and incomplete pathological response (non-pCR). When a K trans of 0.66 emerged as the best cut-off for distinguishing pCR from non-pCR, the sensitivity and specificity for predicting pCR were 100% and 73%, respectively. Martens et al. 38 reported that pretherapy late slope of time-intensity curve on dynamic contrast-enhanced MRI using blood pool contrast agent was a potential kinetic factor to discriminate between good and poor responders after chemoradiotherapy. Diagnostic ability of the late slope was sensitivity 92% and specificity 82%. K trans and late slope also may be useful to predict tumor response after NAC as well as chemoradiotherapy. Because dynamic contrast-enhanced MRI was not performed in this study, it would be necessary to compare the diagnostic ability of APTWI SI with those of K trans and late slope in the future.
Our study has some limitations. First, the patient number was small (n = 17). Selection bias may thus have been present, and more cases should be utilized to confirm the validity of our results in the future. Second, the NAC regimens were not constant. However, a fluorouracil-based drug and oxaliplatin were administered to essentially all patients. The differences in NAC regimens would thus seem to have little effect on our results. Third, we did not compare the APTWI SI with genetic markers related to chemoresistance including DNA mismatch repair, microsatellite instability, and glutathione S-transferase p1 2,39-41 because they were examined only in several cases. Such a comparison should be performed in the future. Fourth, although APT measurement by placing a ROI on a single image was reproduced in this study, the between-session reproducibility of APT measurement for rectal cancers remains unclear. It is an important issue to be investigated hereafter. Fifth, APT measurement was performed on a single slice in this study. For detailed assessment, the wide coverage of a lesion is ideal. Three-dimensional acquisition method of APT imaging suitable for body scanning is desirable.
In conclusion, pretherapeutic APT imaging can be used to predict the tumor response to NAC in locally advanced rectal cancer. The APTWI SI could be superior to the ADC for predicting this tumor response.
